PHRX.US Pharmagen Inc
- Market cap
- USD 5.17K
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2014.
Is PHRX.US undervalued?
Graham numberThe Graham number of Pharmagen Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Pharmagen Inc fundamental analysis
No fundamental analysis for Pharmagen Inc yet.
Pharmagen Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Pharmagen Inc
Pharmagen, Inc. distributes specialty drugs to hospitals, acute care facilities, surgery centers, and other healthcare practitioners in the United States. The company sources and distributes specialty drugs, blood plasma derivatives, specialty products, vaccines, anti-infectives, and hard-to-find pharmaceuticals. It offers plasma derivatives for treating serious medical conditions, such as cancer, hemophilia, rheumatoid arthritis, multiple scleroses, blood disorders, hepatit…
Full company profilePharmagen Inc financial statements
2014 annualized: Fiscal year 2014 is not finished. Income statement and cash flow are annualized from 1 quarter up to Mar 31, 2014, the balance sheet is the latest quarter. Figures change when the annual report is published.
Pharmagen Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2010 | 2011 | 2012 | 2013 | 2014 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 75.3K | 863K | 4.26M | 4.81M | 5.28M |
| Gross Profit | 66.1K | 409K | 1.26M | 3.05M | 2.95M |
| Operating Income | -2.11K | -283K | -2.10M | -2.16M | -1.64M |
| Net Income | -9.33K | -297K | -2.77M | -6.00M | -2.85M |
| Balance Sheet | |||||
| Total Assets | 108K | 305K | 2.90M | 1.28M | 1.28M |
| Total Liabilities | 187K | 674K | 5.59M | 8.87M | 9.08M |
| Shareholders' Equity | -78.8K | -370K | -2.69M | -7.59M | -8.03M |
| Cash & Short-term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow | |||||
| Operating Cash Flow | 7.05K | -255K | -2.18M | -692K | 193K |
| Capital Expenditure | 56.9K | 56.9K | 94.0K | 56.7K | 249K |
| Ratios | |||||
| ROA | -8.7% | -97.4% | -95.6% | -468.0% | -222.8% |
| Net Profit Margin | -12.4% | -34.4% | -65.0% | -124.7% | -54.0% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Pharmagen Inc dividends
Pharmagen Inc has not paid dividends in the last 4 fiscal years.
Last stock split: 45:1 on Dec 7, 2011.
Who owns Pharmagen Inc
Ownership data of Pharmagen Inc is not available yet.
Pharmagen Inc company profile
- Company name
- Pharmagen Inc
- Ticker
- PHRX.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 24
- Fiscal year end
- December
- Address
- 9337 Fraser Avenue, Silver Spring, MD, United States, 20910
- Phone
- 204-898-8160
- Website
- pharmageninc.com
About Pharmagen Inc
Pharmagen, Inc. distributes specialty drugs to hospitals, acute care facilities, surgery centers, and other healthcare practitioners in the United States. The company sources and distributes specialty drugs, blood plasma derivatives, specialty products, vaccines, anti-infectives, and hard-to-find pharmaceuticals. It offers plasma derivatives for treating serious medical conditions, such as cancer, hemophilia, rheumatoid arthritis, multiple scleroses, blood disorders, hepatitis, and HIV; and specialty products for treating respiratory, oncology, cardiovascular, and hormonal syndromes. The company also manufactures and distributes health supplements, including Clotamin, a specialized over-the-counter multivitamin dietary supplement for patients on Warfarin. In addition, it sells traditional pharmaceuticals to its distribution customers, such as antibiotics, vaccines, and other oral and injectable pharmaceuticals; and specializes in the formulation of drugs. The company was formerly known as Sunpeaks Ventures, Inc. and changed its name to Pharmagen, Inc. in January 2013. Pharmagen, Inc. is based in Silver Spring, Maryland.
Pharmagen Inc management
1- Mr. Mackie A. BarchFounder and Vice Chairman · born 1975